GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
6.85
-0.54 (-7.31%)
At close: Dec 20, 2024, 4:00 PM
7.19
+0.34 (4.96%)
After-hours: Dec 20, 2024, 7:37 PM EST
GH Research Market Cap
GH Research has a market cap or net worth of $356.39 million as of December 20, 2024. Its market cap has increased by 14.18% in one year.
Market Cap
356.39M
Enterprise Value
163.28M
1-Year Change
14.18%
Ranking
Category
Stock Price
$6.85
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $356.39M, a decrease of -55.91%. That is a compound annual growth rate of -20.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 356.39M | 18.12% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akebia Therapeutics | 390.54M |
| Enhabit | 387.19M |
| Alpha Teknova | 385.95M |
| Allogene Therapeutics | 385.80M |
| Nano-X Imaging | 384.49M |
| Y-mAbs Therapeutics | 383.84M |
| Quanterix | 383.41M |
| Taysha Gene Therapies | 379.15M |